Texas-based developer of Rapid Acoustic Pulse devices for tattoo removal and cellulite appearance, listed on NASDAQ.
Founded in 2012 by Walter V. Klemp and Christopher Capelli and based in Texas, US, Soliton, Inc. develops Rapid Acoustic Pulse (RAP) devices that accelerate tattoo removal and temporarily improve the appearance of cellulite. Its FDA-cleared product, Resonic, is a non-invasive accessory to a 1064 nm Q-Switched laser for black ink tattoo removal. The company trades on the NASDAQ Capital Market under the ticker SOLY. In 2020 it priced 4,216,868 shares of common stock at USD 8.30 per share, for total gross proceeds of USD 35 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in